← Back to Clinical Trials
Recruiting NCT05036629

Development of MRI Protocols and Associated Neuro-physiological Explorations in Healthy and Pathological Subjects

Trial Parameters

Condition MRI
Sponsor University Hospital, Grenoble
Study Type INTERVENTIONAL
Phase N/A
Enrollment 600
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-09-09
Completion 2026-09-08
Interventions
MRI Protocol

Brief Summary

IRMaGe is a Joint Service Unit (UMS) which provides users of brain exploration equipment (clinical MRI and preclinical, TMS, EEG, NIRS and metabolomics). The methods available on this equipment are intended to evolve according to the most recent discoveries and this protocol aims to frame the developments necessary around clinical MRI for IRMaGe can continue to offer tools at the cutting edge of technology.

Eligibility Criteria

Inclusion Criteria: * Participants with normal or corrected vision * Participants affiliated to a social security scheme or beneficiaries of such a scheme * Participants with French as their mother tongue * Participants who have given the signed informed consent before carrying out any procedure related to the study. * Volunteer patients will be recruited as part of their follow-up at the CHU. Their pathology will be in agreement with that of the research protocol to be optimized. Exclusion Criteria: Criteria relating to contraindications to the explorations provided for by the MRI protocol: * metallic glitter in the eyes * retinal operation * claustrophobia * wearer of pacemaker or cardiac defribrillator or vascular clip or prosthesis cardiac or insulin pump or implanted device to deliver medication or hearing implant or prosthesis or vascular shunt or paragraph or screws, plate metal or tattoo or piercing or implanted metal object or lead shot hunt * Alcohol ingestion before the exam

Related Trials